Osteolytic Lesion in PAPA Syndrome Responding to Anti-interleukin 1 Treatment

被引：24
|
作者：
Caorsi, Roberta
Picco, Paolo
Buoncompagni, Antonella
Martini, Alberto
Gattorno, Marco
机构：
[1] Ist Giannina Gaslini, Unita Operat Pediat 2, I-16147 Genoa, Italy
[2] Univ Genoa, Dept Pediat, Genoa, Italy
来源：
JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 11期
关键词：
RECURRENT MULTIFOCAL OSTEOMYELITIS; AUTOINFLAMMATORY DISORDER; MAJEED-SYNDROME; MUTATIONS;
D O I：
10.3899/jrheum.140060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2333 / 2334
页数：2
相关论文
共 50 条
  • [31] Anti-interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report
    Spagnuolo, Rocco
    Dastoli, Stefano
    Silvestri, Martina
    Cosco, Cristina
    Garieri, Pietro
    Bennardo, Luigi
    Nistico, Steven Paul
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [32] Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment
    Nishida, S.
    Hagihara, K.
    Shima, Y.
    Kawai, M.
    Kuwahara, Y.
    Arimitsu, J.
    Hirano, T.
    Narazaki, M.
    Ogata, A.
    Yoshizaki, K.
    Kawase, I.
    Kishimoto, T.
    Tanaka, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) : 1235 - 1236
  • [33] Interleukin-1 receptor antagonist treatment revealed active hepatitis B infection in a boy with PAPA syndrome
    Selmanovic V.
    DeBenedeti F.
    Omercahić-Dizdarevic A.
    Kovac-Vidakovic E.
    Mehanic S.
    Cengic A.
    Pediatric Rheumatology, 13 (Suppl 1)
  • [34] Refractory serum immunoglobulin M elevation during anti-interleukin (IL)-1-or IL-6-targeted treatment in four patients with Schnitzler syndrome
    Takimoto-Ito, Riko
    Kambe, Naotomo
    Kogame, Toshiaki
    Otsuka, Atsushi
    Nomura, Takashi
    Izawa, Kazushi
    Tabuchi, Yuya
    Yoshifuji, Hajime
    Takeuchi, Yohei
    Kabashima, Kenji
    JOURNAL OF DERMATOLOGY, 2021, 48 (11): : 1789 - 1792
  • [35] Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia
    Kurosawa, Motohiro
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (02) : 154 - 155
  • [36] Tocilizumab: a novel humanized anti-interleukin 6 receptor antibody for the treatment of patients with rheumatoid arthritis
    Alten, Rieke
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2011, 3 (03) : 133 - 149
  • [37] ANTI-INTERLEUKIN 1 THERAPY IN FMF AMYLOIDOSIS: A SINGLE CENTER EXPERIENCE (CASE SERIES)
    Ugurlu, S.
    Ergezen, B.
    Hacioglu, A.
    Ozdogan, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 412 - 412
  • [38] Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis
    Masood, Saad
    Paracha, Muhammad Rafay
    Ahmed, Sophia
    Malik, Maha
    Khalid, Abdur Rehman
    Khalid, Muhammad Hamza
    Fatima, Laveeza
    Nasir, Beena Muntaha
    Rahman, Shafiq Ur
    Khan, Komal
    Ahmad, Farooq
    ALLERGY AND ASTHMA PROCEEDINGS, 2025, 46 (02) : e24 - e32
  • [39] A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model
    Mine Islimye Taskin
    Aysenur Cakir Gungor
    Ertan Adali
    Arzu Yay
    Gozde Ozge Onder
    Umit Inceboz
    Reproductive Sciences, 2016, 23 : 662 - 669
  • [40] A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model
    Taskin, Mine Islimye
    Gungor, Aysenur Cakir
    Adali, Ertan
    Yay, Arzu
    Onder, Gozde Ozge
    Inceboz, Umit
    REPRODUCTIVE SCIENCES, 2016, 23 (05) : 662 - 669
12345